Cardiomyopathy in diabetics: A review of current opinion on the underlying pathological mechanisms

Avances en Diabetologia

Volumn 27, Issue 5, 2011, Pages 175-181

  Ashrafi, Reza ^a   Davis, Gershan ^a  

^a University Hospitals Aintree   (United Kingdom)

Author keywords

Cardiac metabolism; Gene expression; Heart failure; Reactive oxygen Species

Indexed keywords

CALCIUM; FATTY ACID TRANSPORTER; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MYOCYTE ENHANCER FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASOPRESSIN;

AUTONOMIC NEUROPATHY; CARDIAC AUTONOMIC NEUROPATHY; CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC PATIENT; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART; HEART FAILURE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

EID: 84855503468     PISSN: 11343230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avdiab.2011.08.002     Document Type: Short Survey

References (51)

1. S. Rubler, J. Dlugash, Y.Z. Yuceoglu, T. Kumral, A.W. Branwood, and A. Grishman New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 1972 595 602
2. J.D. Horowitz, and J.A. Kennedy Time to address the cardiac metabolic "triple whammy" ischemic heart failure in diabetic patients J Am Coll Cardiol 48 2006 2232 2234
3. W.B. Kannel, M. Hjortland, and W.P. Castelli Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 1974 29 34
4. G. Kouvaras, D. Cokkinos, and M. Spyropoulou Increased mortality of diabetics after acute myocardial infarction attributed to diffusely impaired left ventricular performance as assessed by echocardiography Jpn Heart J 29 1988 1 9
5. P. Varadarajan, and R.G. Pai Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients J Card Fail 9 2003 107 112 (Pubitemid 36444195)
6. M. Salem, S. El Behery, A. Adly, D. Khalil, and E. El Hadidi Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus Pediatr Diabetes 10 2009 513 521
7. V. Sharma, and J.H. McNeill Diabetic cardiomyopathy: where are we 40 years later? Can J Cardiol 22 2006 305 308
8. D.P. Dutka, M. Pitt, D. Pagano, M. Mongillo, D. Gathercole, and R.S. Bonser Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease J Am Coll Cardiol 48 2006 2225 2231 (Pubitemid 44855434)
9. S. Boudina, and E.D. Abel Diabetic cardiomyopathy, causes and effects Rev Endocr Metab Disord 11 2010 31 39
10. D. An, and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol 291 2006 H1489 H1506
11. L.J. Rijzewijk, R.W. van der Meer, H.J. Lamb, H.W. de Jong, M. Lubberink, and J.A. Romijn Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging J Am Coll Cardiol 54 2009 1524 1532
12. S. Boudina, and E.D. Abel Diabetic cardiomyopathy revisited Circulation 115 2007 3213 3223 (Pubitemid 47012236)
13. B.N. Finck The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart Curr Opin Clin Nutr Metab Care 7 2004 391 396 (Pubitemid 40340644)
14. Khullar M, Al-Shudiefat AA, Ludke A, Binepal G, Singal PK. Oxidative stress: a key contributor to diabetic cardiomyopathy. Can J Physiol Pharmacol;88(3):233-40.
15. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820 (Pubitemid 34000785)
16. A.P. Rolo, and C.M. Palmeira Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress Toxicol Appl Pharmacol 212 2006 167 178
17. I. Gabriely, X.M. Yang, J.A. Cases, X.H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway Atherosclerosis 160 2002 115 122 (Pubitemid 34076647)
18. X.L. Du, D. Edelstein, L. Rossetti, I.G. Fantus, H. Goldberg, and F. Ziyadeh Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation Proc Natl Acad Sci U S A 97 2000 12222 12226
19. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, and Y. Kaneda Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790 (Pubitemid 30212409)
20. M.B. Davidson, G. Bate, and P. Kirkpatrick Exenatide Nat Rev Drug Discov 4 2005 713 714
21. H. Bugger, D. Chen, C. Riehle, J. Soto, H.A. Theobald, and X.X. Hu Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice Diabetes 58 2009 1986 1997
22. H. Bugger, S. Boudina, X.X. Hu, J. Tuinei, V.G. Zaha, and H.A. Theobald Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3 Diabetes 57 2008 2924 2932
23. M. Rota, N. LeCapitaine, T. Hosoda, A. Boni, A. De Angelis, and M.E. Padin-Iruegas Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene Circ Res 99 2006 42 52 (Pubitemid 44297054)
24. D. Cesselli, I. Jakoniuk, L. Barlucchi, A.P. Beltrami, T.H. Hintze, and B. Nadal-Ginard Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy Circ Res 89 2001 279 286 (Pubitemid 34132687)
25. E. Messina, and A. Giacomello Diabetic cardiomyopathy: a "cardiac stem cell disease" involving p66Shc, an attractive novel molecular target for heart failure therapy Circ Res 99 2006 1 2 (Pubitemid 44297046)
26. D.M. Bers Cardiac excitation-contraction and coupling Nature 415 2002 198 205
27. C.H. Shao, X.H. Wehrens, T.A. Wyatt, S. Parbhu, G.J. Rozanski, and K.P. Patel Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation J Appl Physiol 106 2009 1280 1292
28. P. Razeghi, M.E. Young, T.C. Cockrill, O.H. Frazier, and H. Taegtmeyer Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure Circulation 106 2002 407 411 (Pubitemid 34803682)
29. K.R. Bidasee, K. Nallani, Y. Yu, R.R. Cocklin, Y. Zhang, and M. Wang Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels Diabetes 52 2003 1825 1836 (Pubitemid 36805580)
30. C.H. Shao, G.J. Rozanski, K.P. Patel, and K.R. Bidasee Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats J Mol Cell Cardiol 42 2007 234 246 (Pubitemid 44958613)
31. M.A. Pfeifer, C.R. Weinberg, D.L. Cook, A. Reenan, J.B. Halter, and J.W. Ensinck Autonomic neural dysfunction in recently diagnosed diabetic subjects Diabetes Care 7 1984 447 453 (Pubitemid 14048613)
32. M.F. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, and O. Muzik Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus Circulation 100 1999 813 819 (Pubitemid 29398878)
33. M.J. Stevens, F. Dayanikli, D.M. Raffel, K.C. Allman, T. Sandford, and E.L. Feldman Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy J Am Coll Cardiol 31 1998 1575 1584 (Pubitemid 28273301)
34. B.W. Stewart Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators J Natl Cancer Inst 86 1994 1286 1296 (Pubitemid 24276790)
35. M. Chottova Dvorakova, J. Kuncova, U. Pfeil, G.P. McGregor, J. Sviglerova, and J. Slavikova Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats Neuroscience 134 2005 51 58 (Pubitemid 40943633)
36. S. Enhorning, T.J. Wang, P.M. Nilsson, P. Almgren, B. Hedblad, and G. Berglund Plasma copeptin and the risk of diabetes mellitus Circulation 121 2010 2102 2108
37. C. Maier, M. Clodi, S. Neuhold, M. Resl, M. Elhenicky, and R. Prager Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes Diabetes Care 32 2009 1890 1895
38. Y. Fujiwara, M. Hiroyama, A. Sanbe, T. Aoyagi, J. Birumachi, and J. Yamauchi Insulin hypersensitivity in mice lacking the V1b vasopressin receptor J Physiol 584 Pt 1 2007 235 244 (Pubitemid 47500551)
39. Masson S, Latini R, Carbonieri E, Moretti L, Rossi MG, Ciricugno S, et al. The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial. Eur J Heart Fail;12(4):338-47.
40. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, et al. Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol;10:34.
41. C.L. Holmes, D.W. Landry, and J.T. Granton Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology Crit Care 8 2004 15 23 (Pubitemid 38202135)
42. A.K. Das, J.P. Das, and S. Chandrasekar Specific heart muscle disease in diabetes mellitus - a functional structural correlation Int J Cardiol 17 1987 299 302 (Pubitemid 17153742)
43. K.J. Way, K. Isshiki, K. Suzuma, T. Yokota, D. Zvagelsky, and F.J. Schoen Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes Diabetes 51 2002 2709 2718 (Pubitemid 34970923)
44. S. Chen, T. Evans, K. Mukherjee, M. Karmazyn, and S. Chakrabarti Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors J Mol Cell Cardiol 32 2000 1621 1629
45. H. Vlassara Advanced glycation end-products and atherosclerosis Ann Med 28 1996 419 426 (Pubitemid 26380001)
46. R. Candido, J.M. Forbes, M.C. Thomas, V. Thallas, R.G. Dean, and W.C. Burns A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circ Res 92 2003 785 792 (Pubitemid 36457644)
47. M. Cheng, H.Q. Gao, L. Xu, B.Y. Li, H. Zhang, and X.H. Li Cardioprotective effects of grape seed proanthocyanidins extracts in streptozocin induced diabetic rats J Cardiovasc Pharmacol 50 2007 503 509 (Pubitemid 350146452)
48. Ruan BH, Li X, Winkler AR, Cunningham KM, Kuai J, Greco RM, et al. Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-alpha production in a receptor for advanced glycation end product-dependent manner. J Immunol;185(7):4213-22.
49. Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, Leccisotti L, et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J;31(1):100-11.
50. H. Bahrami, D.A. Bluemke, R. Kronmal, A.G. Bertoni, D.M. Lloyd-Jones, and E. Shahar Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 51 2008 1775 1783 (Pubitemid 351608497)
51. F.P. Xu, M.S. Chen, Y.Z. Wang, Q. Yi, S.B. Lin, and A.F. Chen Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes Circulation 110 2004 1269 1275 (Pubitemid 39202344)